We know community pharmacies continue to be frustrated by issues plaguing the iPLEDGE REMS system. On Wednesday, the manufacturers of the isotretinoin products hosted a call for pharmacy stakeholders to discuss possible workarounds so patient access isn't impeded and patient safety is maintained. NCPA participated on this call on behalf of independent pharmacy. The workarounds for when a prescriber can't access the iPLEDGE portal in discussion include a paper-based form from the prescriber to the pharmacy in conjunction with a universal RMA number or no RMA number being required. Please note a final decision has not been made and the manufacturers cannot offer a timeline for resolution. NCPA has alerted the manufacturers and FDA of the non-responsiveness of the iPLEDGE call center number as well as multiple technical issues accessing the iPLEDGE online portal. For now, if you do not have access to your account on the website, please continue to contact the iPLEDGE call center at 866-495-0654.
NCPA
